Heart Failure: Gaps in Knowledge and Failures in Treatment
article has not abstract
Vyšlo v časopise:
Heart Failure: Gaps in Knowledge and Failures in Treatment. PLoS Med 11(8): e32767. doi:10.1371/journal.pmed.1001702
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001702
Souhrn
article has not abstract
Zdroje
1. CallenderT, WoodwardM, RothG, FarzadfarF, LemarieJ-C, et al. (2014) Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med 11: e1001699.
2. GlasziouP (2014) The role of open access in reducing waste in medical research. PLoS Med 11: e1001651.
3. PittB, PfefferMA, AssmannSF, BoineauR, AnandIS, et al. (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370: 1383–1392.
4. McMurrayJJV, O'ConnorC (2014) Lessons from the TOPCAT trial. New Engl J Med 370: 1453–1454.
5. OwanTE, HodgeDO, HergesRM, JacobsenSJ, RogerVL, et al. (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. New Engl J Med 355: 251–259.
6. RedfieldMM, JacobsenSJ, BurnettJCJr, MahoneyDW, BaileyKR, et al. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289: 194–202.
7. McDonaghTA, MorrisonCE, LawrenceA, FordI, Tunstall-PedoeH, et al. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350: 829–833.
8. MasoudiFA, HavranekEP, SmithG, FishRH, SteinerJF, et al. (2003) Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41: 217–223.
9. LindenfeldJ, Krause-SteinraufH, SalernoJ (1997) Where are all the women with heart failure. J Am Coll Cardiol 30: 1417–1419.
10. YancyCW, LopatinM, StevensonLW, MarcoTD, FonarowGC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function : a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol 47: 76–84.
11. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) (2012) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 33: 1750–1757.
12. HoekstraT, Lesman-LeegteI, van VeldhuisenDJ, SandermanR, JaarsmaT (2011) Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail 13: 1013–1018.
13. McMurrayJJ, AdamopoulosS, AnkerSD, AuricchioA, BöhmM, et al. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14: 803–869.
14. YancyCW, JessupM, BozkurtB, ButlerJ, CaseyDE, et al. (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62: e147–e239.
15. NieminenMS, BrutsaertD, DicksteinK, DrexlerH, FollathF, et al. (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27: 2725–2736.
16. Statistics South Africa (2014) Mortality and causes of death in South Africa, 2011: findings from death notification. Available: http://beta2.statssa.gov.za/publications/P03093/P030932011.pdf. Accessed 10 July 2014.
17. AdjuikM, SmithT, ClarkS, ToddJ, GarribA, et al. (2006) Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ 84: 181–188.
18. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302.
19. The Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316: 1429–1435.
20. PittB, ZannadF, RemmeWJ, CodyR, CastaigneA, et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341: 709–717.
21. LechatP, PackerM, ChalonS, CucheratM, ArabT, et al. (1998) Clinical effects of β-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98: 1184–1191.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Women's Access and Provider Practices for the Case Management of Malaria during Pregnancy: A Systematic Review and Meta-Analysis
- Observational Studies: Getting Clear about Transparency
- Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
- Scaling up Rural Sanitation in India